Michael Kiernan to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Michael Kiernan has written about Dose-Response Relationship, Drug.
Connection Strength
0.396
-
Kiernan MS, Stevens SR, Tang WHW, Butler J, Anstrom KJ, Birati EY, Grodin JL, Gupta D, Margulies KB, LaRue S, D?vila-Rom?n VG, Hernandez AF, de las Fuentes L. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials. J Card Fail. 2018 Jul; 24(7):428-438.
Score: 0.128
-
Kiernan MS, Gregory D, Sarnak MJ, Rossignol P, Massaro J, Kociol R, Zannad F, Konstam MA. Early and late effects of high- versus low-dose angiotensin receptor blockade on renal function and outcomes in patients with chronic heart failure. JACC Heart Fail. 2015 Mar; 3(3):214-23.
Score: 0.104
-
Kiernan MS, Wentworth D, Francis G, Martinez FA, Dickstein K, Komajda M, Zannad F, Neaton JD, Konstam MA. Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial. Eur J Heart Fail. 2012 Dec; 14(12):1401-9.
Score: 0.089
-
Natov PS, Ivey-Miranda JB, Cox ZL, Rao VS, Butler J, Konstam MA, Kiernan MS, Kapur NK, Testani JM. Increased Spironolactone Dosing in Acute Heart Failure Alters Potassium Homeostasis but Does not Enhance Decongestion. J Card Fail. 2024 Nov; 30(11):1522-1526.
Score: 0.050
-
Borden M, Kiernan MS, Pham DT, DeNofrio D, Sylvia L. Bridging with half-therapeutic dose enoxaparin in outpatients with left ventricular assist devices and sub-therapeutic international normalized ratios. J Heart Lung Transplant. 2015 Jun; 34(6):860-2.
Score: 0.026